Search details
1.
Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
Cancer Sci
; 115(5): 1622-1633, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38429886
2.
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
Br J Cancer
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38834744
3.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-37331369
4.
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
Ann Surg Oncol
; 31(6): 3872-3879, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38353798
5.
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC.
Future Oncol
; 20(11): 653-663, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37815847
6.
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
Future Oncol
; 20(7): 393-407, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37850363
7.
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.
Future Oncol
; 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38629456
8.
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay.
Int J Clin Oncol
; 29(5): 495-511, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38551727
9.
Learning Outcomes of "GetSMART," Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers.
J Cancer Educ
; 39(2): 118-125, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38135836
10.
[Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer].
Gan To Kagaku Ryoho
; 51(3): 245-249, 2024 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-38494801
11.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36369901
12.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36871043
13.
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Br J Cancer
; 128(8): 1603-1608, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36782009
14.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37532830
15.
Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review.
Oncologist
; 28(11): e981-e994, 2023 Nov 02.
Article
in English
| MEDLINE | ID: mdl-37432264
16.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Article
in English
| MEDLINE | ID: mdl-33264544
17.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-37605122
18.
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance.
Int J Clin Oncol
; 28(1): 130-138, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36307632
19.
Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: an early post-marketing phase vigilance study.
Int J Clin Oncol
; 28(1): 139-144, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36355316
20.
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy.
Int J Clin Oncol
; 28(2): 306-313, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36527579